Mononine®

Mononine® is indicated for the prevention and control of bleeding in Factor IX deficiency, also known as Hemophilia B or Christmas disease.

Mononine® is not indicated in the treatment or prophylaxis of Hemophilia A patients with inhibitors to Factor VIII.

Mononine® contains non-detectable levels of Factors II, VII and X (<0.0025 IU per Factor IX unit using standard coagulation assays) and is, therefore, not indicated for replacement therapy of these clotting factors.

Mononine® is also not indicated in the treatment or reversal of coumarin-induced anticoagulation or in a hemorrhagic state caused by hepatitis-induced lack of production of liver dependent coagulation factors.

For indications, dosing and other information, please refer to the prescribing information.

Mononine® ‐ CSL Behring

Size:
500 unit, 5 mL vial
NDC #:
00053-6232-02
Download:
PI
Size:
1000 unit, 10 mL vial
NDC #:
00053-6233-02
Download:
PI